Cambridge Investment Research Advisors, Inc.
Position in DXCM — Dexcom Inc
CIK 1419186
FAIRFIELD, IA
Position in DXCM
as of Mar 31, 2026
· filed Apr 30, 2026
Position Value
$3,158,463
+$605,940 QoQ
Shares Held
50,294
+30.8% QoQ
Ownership
0.013%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Common Shares in DXCM Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Mar 31, 2026Cambridge Investment Research Advisors, Inc. holds $100,026,792 across 24 Medical Devices names. DXCM ranks #6 (3.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
302,423 | $31,049,769 | |
| 2 | SYK |
Stryker Corp
|
77,649 | $25,514,684 | |
| 3 | MDT |
Medtronic plc
|
224,017 | $19,411,073 | |
| 4 | GEHC |
GE HealthCare Technologies Inc.
|
85,273 | $6,069,732 | |
| 5 | BSX |
Boston Scientific Corp
|
53,823 | $3,377,393 | |
| 6 | DXCM |
Dexcom Inc
This page
|
50,294 | $3,158,463 | |
| 7 | STE |
STERIS plc
|
10,820 | $2,392,626 | |
| 8 | EW |
Edwards Lifesciences Corp
|
28,422 | $2,276,033 |
All Filings in DXCM
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,158,463 | 50,294 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $2,552,523 | 38,459 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $880,018 | 13,078 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $3,244,220 | 37,166 | Shares | Sole | 2025-07-31 | |
| 2025-03-31 | $1,550,661 | 22,707 | Shares | Sole | 2025-04-22 | |
| 2024-12-31 | $1,897,432 | 24,398 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $1,733,520 | 25,858 | Shares | Sole | 2024-10-28 | |
| 2024-06-30 | $3,361,263 | 29,646 | Shares | Sole | 2024-07-26 | |
| 2024-03-31 | $7,110,455 | 51,265 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $8,429,681 | 67,932 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,468,997 | 26,463 | Shares | Sole | 2023-10-24 | |
| 2023-06-30 | $2,729,680 | 21,241 | Shares | Sole | 2023-07-13 | |
| 2023-03-31 | $4,003,795 | 34,462 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,862,707 | 25,280 | Shares | Sole | 2023-02-08 | |
| 2022-09-30 | $1,741,596 | 21,624 | Shares | Sole | 2022-10-17 | |
| 2022-06-30 | $1,530,995 | 20,542 | Shares | Sole | 2022-07-13 | |
| 2022-03-31 | $757,935 | 5,926 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $988,659 | 7,365 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,168,092 | 8,544 | Shares | Sole | 2021-11-02 | |
| 2021-06-30 | $766,358 | 7,179 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $695,599 | 7,742 | Shares | Sole | 2021-05-07 | |
| 2020-12-31 | $521,490 | 5,642 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $537,857 | 5,219 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $694,348 | 6,851 | Shares | Sole | 2020-07-27 | |
| 2020-03-31 | $297,206 | 4,415 | Shares | Sole | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||